 | Regeneron Pharmaceuticals, Inc. | |||
| NMS : REGN || Location: United States | ||||
$893.99-7.2 (-0.8%) |
0.45 M | 891.67 - 908.81 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.421 M |
| March 15, 2024 | 1.392 M |
| Feb. 29, 2024 | 1.357 M |
| Feb. 15, 2024 | 1.370 M |
| Jan. 31, 2024 | 1.250 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 10.95 | 11.86 | 8.36% |
| 09/30/2023 | 10.93 | 11.59 | 6.01% |
| 06/30/2023 | 10.04 | 10.24 | 1.99% |
| 03/31/2023 | 9.75 | 10.09 | 3.50% |
| 12/31/2022 | 10.23 | 12.56 | 22.77% |
REGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 107.944M | Shares Float | 102.753M |
| Short Float | 1.421M | Market Cap | 96500.86M |
| Institution ownership | 89.25% | Insider ownership | 2.582% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 34.77 | Forward EPS | 47.54 |